Market Outlook

By 2035, the U.S. Connected Home Healthcare Devices Market is expected to reach approximately USD 95.38 billion, expanding at a CAGR of 12.80% during the forecast period 2026–2035. The market is estimated at USD 28.60 billion in 2025, with historical analysis covering 2021 to 2024. Values in this report are expressed in USD billions.

The historical market expanded from approximately USD 13.70 billion in 2021 to USD 24.80 billion in 2024, representing a period of accelerated adoption following the normalization of telehealth, remote patient monitoring, continuous glucose monitoring, connected respiratory care, virtual chronic-disease management, and hospital-to-home programs. The market reached approximately USD 16.80 billion in 2022 and USD 20.60 billion in 2023 before increasing to USD 28.60 billion in 2025. Based on the forecast model, revenue is expected to reach approximately USD 32.26 billion in 2026 and continue expanding toward USD 95.38 billion by 2035.

The U.S. connected home healthcare devices industry is shifting from a collection of standalone monitoring products into an integrated medical-device ecosystem built around continuous data collection, automated transmission, clinician visibility, patient self-management, and earlier intervention. Connected blood pressure monitors, continuous glucose monitors, wearable ECG patches, pulse oximeters, connected scales, respiratory therapy systems, sleep devices, digital medication systems, home diagnostic tools, fall-detection technologies, and multi-parameter monitoring platforms are increasingly becoming extensions of formal clinical care rather than optional consumer accessories.

A central structural driver is the scale of chronic disease in the United States. Approximately 194 million U.S. adults reported at least one selected chronic condition in 2023, while more than half of adults reported multiple chronic conditions. Hypertension alone affects close to 120 million adults. Diabetes affects tens of millions of Americans, while heart failure, chronic respiratory disease, obesity, sleep disorders, and age-related functional limitations create additional demand for monitoring outside institutional settings.

The aging population strengthens this demand. The number of Americans aged 65 and older reached more than 61 million in 2024 and now represents approximately 18% of the population. Older Americans increasingly want to remain at home, while health systems and payers need scalable mechanisms for managing clinical risk without relying exclusively on hospital beds, emergency departments, specialist visits, or skilled nursing facilities.

Connected home healthcare devices therefore sit at the intersection of medical-device spending, chronic-disease management, virtual care, Medicare economics, hospital capacity management, and consumer technology adoption. The market opportunity is not simply the number of connected devices shipped. Revenue is increasingly influenced by replacement cycles, recurring sensors, consumables, bundled connectivity, data platforms, device provisioning, monitoring infrastructure, clinical integration, and disease-specific care pathways.

The strongest growth through 2035 is expected in connected diabetes management, multi-parameter remote physiologic monitoring, wearable cardiovascular monitoring, home respiratory and sleep therapy, post-discharge monitoring, and devices supporting higher-acuity care in the home. Manufacturers capable of combining clinically validated hardware with reliable connectivity, interoperable data, intuitive patient interfaces, cybersecurity, and measurable provider economics will capture disproportionate value.

 

Introduction

According to the U.S. Connected Home Healthcare Devices Market Report, the market includes medical devices designed to collect, transmit, analyze, display, or facilitate the clinical use of patient health information from the home or another non-institutional setting. The market includes both patient-operated and caregiver-supported devices and covers technologies prescribed by clinicians, supplied through healthcare organizations, purchased through pharmacies or durable medical equipment channels, and increasingly obtained directly by consumers when cleared for home or over-the-counter use.

The report includes connected physiological monitoring devices, continuous and connected glucose-monitoring technologies, connected respiratory and sleep-therapy devices, medication and therapy-adherence systems, home diagnostic and assessment technologies, remote safety devices, selected wearable medical devices, and multi-device home monitoring platforms. Associated software and connectivity are included where directly bundled with the medical device or required for normal device operation.

The market excludes general-purpose smartphones, conventional telehealth visits, standalone virtual-care software, home-health staffing services, traditional non-connected durable medical equipment, and consumer-only fitness products without a meaningful clinical monitoring or disease-management role. This distinction is essential because the commercial economics of regulated home medical devices differ substantially from the broader digital-health and smart-home markets.

The U.S. is particularly attractive for connected home healthcare device manufacturers because it combines high chronic-disease prevalence, advanced broadband and smartphone adoption, a large Medicare population, sophisticated health systems, strong medical-device reimbursement pathways, venture and strategic investment, and a relatively mature remote-monitoring ecosystem. Older consumers are also becoming increasingly comfortable using smartphones, connected devices, digital health applications, home sensors, and telehealth platforms.

The purchasing environment nevertheless remains fragmented. A connected device may be purchased directly by a patient, distributed by a pharmacy, prescribed by a physician, purchased through an integrated delivery network, supplied through an RPM company, reimbursed by Medicare, embedded in a commercial payer program, or included within a hospital-at-home deployment. Consequently, manufacturers require multiple go-to-market models rather than a single hospital procurement strategy.

The economic value proposition is also changing. Early connected-health programs frequently focused on whether a device could transmit data. Current procurement decisions are more sophisticated. Health systems increasingly ask whether the technology identifies deterioration early enough to change clinical management, reduces avoidable utilization, improves medication adherence, lowers staff workload, supports reimbursement, integrates with existing workflows, and produces data that clinicians can realistically act upon.

Over 2026–2035, the category is expected to evolve from device connectivity toward clinically orchestrated home-care infrastructure. The winning platforms will not simply generate more patient data. They will filter data, prioritize risk, route actionable information to the appropriate clinician, document interventions, and help healthcare organizations manage larger populations with limited clinical labor.

 

Key Market Drivers: What’s Fueling the U.S. Connected Home Healthcare Devices Market Boom?

The first major driver is the enormous U.S. chronic-disease population. Chronic conditions create repeated measurement requirements that are particularly well suited to home monitoring. Hypertension requires blood-pressure tracking, diabetes requires glucose management, heart failure management benefits from weight and physiologic surveillance, respiratory disease requires oxygen and therapy monitoring, while cardiac arrhythmias increasingly rely on ambulatory ECG technologies. Because chronic conditions persist over years rather than isolated treatment episodes, they create recurring opportunities for device replacement, sensors, software, accessories, and monitoring services.

A second major driver is the aging of the U.S. population. More than 61 million Americans are already aged 65 and older, and this population has a substantially higher probability of living with multiple chronic conditions. Older adults are also more likely to experience medication complexity, mobility limitations, fall risk, cardiopulmonary disease, diabetes, cognitive impairment, and repeated transitions between hospital, rehabilitation, skilled nursing, home health, and independent living. Connected devices offer an increasingly practical infrastructure for aging in place while maintaining clinical oversight.

A third driver is reimbursement for remote monitoring. Medicare has established a framework for remote physiologic monitoring and remote therapeutic monitoring, enabling eligible clinicians to receive payment for device setup, data collection, and patient-management activities when program requirements are satisfied. Medicare payments for RPM surpassed USD 500 million in 2024, demonstrating that remote monitoring has moved beyond pilot-stage reimbursement. The economics remain subject to coding rules and policy refinement, but the existence of recurring reimbursement materially improves provider willingness to deploy connected devices.

A fourth driver is hospital capacity pressure and the migration of care into the home. Hospital-at-home, post-discharge monitoring, transitional care, oncology-at-home, home-based primary care, and virtual nursing models are expanding the clinical intensity of home care. The Acute Hospital Care at Home model has provided U.S. hospitals with practical experience managing selected inpatient-level patients outside hospital walls, and federal authorization for the initiative has been extended through September 2030. These models require dependable home monitoring because clinical teams must recognize deterioration without continuous bedside observation.

A fifth driver is rapid consumer technology adoption among older adults. Smartphone ownership among Americans aged 50 and older is now close to universal relative to earlier decades. Large numbers of older consumers also use health applications, connected watches, home safety systems, digital medical services, and telehealth. This substantially reduces one of the historical obstacles to connected medical devices: whether patients possess or understand the technology required to pair, transmit, and view health information.

A sixth driver is the growing economic importance of avoiding preventable utilization. U.S. providers operating under accountable care, Medicare Advantage, bundled-payment, capitated, or other risk-based structures have financial incentives to reduce avoidable emergency department visits, hospitalizations, and readmissions. A connected scale that identifies rapid weight gain in a heart-failure patient or a connected blood-pressure monitor that identifies uncontrolled hypertension can therefore have economic value far beyond the acquisition cost of the device.

A seventh driver is the maturation of home-use device design. Earlier generations of connected healthcare products often relied on complex pairing processes, multiple applications, manual data entry, and unreliable wireless connectivity. New products increasingly use cellular connectivity, automatic synchronization, disposable or semi-disposable sensors, simplified onboarding, longer battery life, and passive data transfer. These features reduce failure points and make population-scale deployment more commercially feasible.

An eighth driver is the expansion of direct-to-consumer access to clinically meaningful technologies. Continuous glucose monitoring provides an important example. Regulatory clearance of over-the-counter CGM technologies has expanded the potential user base beyond traditional insulin-treated diabetes populations. Similar convergence between prescription medical technology and consumer-accessible healthcare is likely to appear across cardiovascular assessment, sleep, respiratory monitoring, hearing, diagnostic testing, and preventive health.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. connected home healthcare devices market is moving away from simple device-to-app connectivity toward continuous clinical intelligence. The competitive question is increasingly whether a device can operate reliably within a full care pathway and whether its data can improve decisions without creating unnecessary clinician workload.

Continuous and minimally intrusive sensing is one of the most important innovation directions. Adhesive patches, miniaturized biosensors, wearable ECG systems, continuous glucose sensors, optical technologies, connected blood-pressure devices, smart scales, and multi-parameter monitors are reducing dependence on episodic measurements. Continuous information can reveal trends that would remain invisible during periodic office visits, particularly for arrhythmia, glycemic variability, sleep disorders, respiratory deterioration, and post-discharge instability.

Artificial intelligence and algorithmic triage are becoming strategically important because connected devices can generate more data than clinical teams can manually review. Algorithms are increasingly being used to detect abnormal patterns, prioritize patient lists, identify arrhythmias, estimate physiologic deterioration, reduce false alarms, and escalate patients according to clinical thresholds. The commercial value of AI will depend less on producing novel scores and more on reducing labor per monitored patient while maintaining clinical safety.

Connected diabetes technology remains one of the fastest-moving innovation categories. Continuous glucose monitors have evolved into compact smartphone-linked platforms that generate real-time glucose trends and increasingly interact with insulin-delivery systems. The arrival of over-the-counter CGM has expanded the addressable U.S. population and introduced new commercial channels. Future growth will be driven by longer sensor life, smaller form factors, improved affordability, interoperability with therapeutic devices, and expansion beyond intensive insulin management.

Home cardiovascular monitoring is also becoming more sophisticated. Connected blood-pressure monitors remain a foundational category because hypertension affects nearly half of U.S. adults, but higher-value growth is occurring in wearable ECG, mobile cardiac telemetry, multi-day patches, connected implant follow-up, and multi-parameter monitoring. The strongest platforms combine diagnostic-quality sensing with automated interpretation and clinician workflows capable of managing large ambulatory populations.

Respiratory and sleep technologies are becoming increasingly connected by default. Positive airway pressure devices, oxygen systems, pulse oximetry, connected inhalers, spirometry, and selected ventilation technologies generate clinically useful adherence or physiologic information. Manufacturers can use connectivity to identify poor therapy compliance, support coaching, troubleshoot devices remotely, and document utilization for providers and payers.

Interoperability represents another major innovation frontier. A typical high-risk home patient may use a blood-pressure cuff, pulse oximeter, scale, CGM, medication system, and wearable sensor from different manufacturers. Healthcare organizations increasingly want these data streams consolidated rather than managed through multiple proprietary dashboards. Manufacturers that support application programming interfaces, standard data formats, EHR connectivity, and multi-device orchestration can reduce integration burden and improve enterprise procurement competitiveness.

Cybersecurity has also become part of core medical-device innovation. Connected medical devices introduce vulnerabilities that traditional standalone home equipment did not face. Device manufacturers must increasingly incorporate secure software architecture, authentication, vulnerability management, patching strategies, software bills of materials, lifecycle security processes, and postmarket surveillance. Cybersecurity performance is becoming an enterprise purchasing requirement, not simply a regulatory documentation exercise.

Human factors are equally important. Home healthcare devices are often operated by elderly patients, family caregivers, or individuals with limited technical experience. Device design therefore must account for poor vision, dexterity limitations, cognitive burden, broadband instability, multilingual households, and the realities of everyday home environments. Products that require repeated pairing, complicated charging, or technical troubleshooting can generate costly program attrition even if the underlying clinical technology is strong.

 

Segmentation Insights

The U.S. Connected Home Healthcare Devices Market is segmented on the basis of product category, application, end user, technology type, and region.

 

By Product Category

Connected Physiological Monitoring Devices

Connected physiological monitoring devices represent one of the largest categories in the U.S. market. The segment includes connected blood-pressure monitors, pulse oximeters, digital thermometers, smart scales, ECG systems, wearable cardiac patches, multiparameter monitors, and selected home diagnostic devices. Blood-pressure monitoring benefits from the enormous hypertension population, while weight and oxygen monitoring are heavily used in heart failure, respiratory disease, and post-discharge programs.

The category is evolving from individually prescribed devices toward multi-device kits. RPM companies and health systems increasingly provision patients with combinations of blood-pressure monitors, scales, pulse oximeters, thermometers, and cellular hubs according to disease pathway. Devices that automatically transmit readings rather than depend on manual patient entry are preferred because they reduce data integrity problems and improve billing compliance.

Connected Diabetes Management Devices

Connected diabetes devices form one of the highest-value categories and include continuous glucose monitors, smart glucose meters, connected insulin pumps, automated insulin-delivery components, connected insulin pens, and associated home diabetes-monitoring systems. Diabetes affects approximately 38 million U.S. adults, creating a very large recurring device population.

CGM is the dominant growth engine because sensor replacement creates recurring revenue and because clinical adoption is expanding beyond historically narrow patient groups. Smartphone integration, longer sensor wear, improved accuracy, automated insulin delivery, Medicare coverage, commercial insurance adoption, and over-the-counter availability are broadening the market. Abbott, Dexcom, Medtronic, Insulet, Tandem Diabetes Care, Roche, Ascensia, and LifeScan participate across different parts of the connected diabetes ecosystem.

Connected Respiratory and Sleep Therapy Devices

This segment includes connected CPAP and bilevel systems, home ventilatory equipment, oxygen-monitoring technologies, pulse oximetry, connected inhalers, home spirometry, sleep assessment devices, and related respiratory monitoring equipment. Sleep apnea, COPD, asthma, post-acute respiratory disease, obesity, and an aging population support long-term demand.

Connected therapy platforms allow providers to monitor adherence, identify mask or pressure problems, detect poor utilization, and intervene without an office visit. For durable medical equipment providers, connectivity can also reduce service calls and support reimbursement documentation. ResMed and Philips remain highly influential, while other respiratory and monitoring companies compete through specialized home therapy and sensing platforms.

Connected Medication and Therapy Adherence Devices

Connected medication-adherence technologies include smart dispensers, electronic pill containers, medication reminders, connected injection support devices, adherence sensors, and related therapy-management tools. The category is smaller than physiologic monitoring or diabetes but addresses a major clinical problem: patients frequently fail to follow complex treatment regimens after leaving healthcare facilities.

The strongest opportunities are in populations where non-adherence creates expensive consequences, including cardiovascular disease, transplantation, behavioral health, oncology, diabetes, and multi-morbidity among older adults. Commercial success requires integration into pharmacy, caregiver, payer, or provider workflows because a standalone reminder device has limited value unless missed doses generate meaningful intervention.

Connected Safety, Aging-in-Place, and Post-Acute Devices

This category covers medical alert technologies, fall-detection devices, activity and mobility sensors, selected ambient monitoring systems, connected diagnostic kits, home assessment tools, and multi-parameter post-acute monitoring platforms. Growth is supported by aging in place and the increasing number of patients discharged from hospitals with unresolved monitoring requirements.

The category is shifting from emergency buttons toward passive sensing and clinically integrated home monitoring. Motion, gait, activity, sleep, vital signs, and environmental data can collectively indicate functional decline. For health systems and Medicare Advantage organizations, the objective is not simply emergency response but earlier identification of deterioration that could lead to hospitalization.

 

By Application

Cardiovascular Disease and Hypertension Management

Cardiovascular and hypertension management represents a major application segment because of the large patient base and the clinical value of repeated measurements. Connected blood-pressure monitoring, weight monitoring, ECG, pulse monitoring, and wearable cardiac devices are increasingly used to support hypertension management, heart-failure surveillance, arrhythmia detection, post-procedure follow-up, and secondary prevention.

The commercial opportunity extends beyond device sales because high-risk cardiovascular patients often require longitudinal monitoring. Providers increasingly value platforms that identify worsening blood pressure, rapid weight change, rhythm abnormalities, or poor medication adherence before an acute event occurs.

Diabetes and Metabolic Disease Management

Diabetes and metabolic disease are among the most commercially attractive connected-home applications. CGM has transformed diabetes management from episodic finger-stick testing into continuous data generation. Connected insulin-delivery systems further increase the value of the ecosystem by linking diagnostics and therapy.

Over the forecast period, the market is expected to broaden from insulin-intensive diabetes toward Type 2 diabetes, prediabetes, metabolic health, and selected consumer-accessible glucose monitoring. However, manufacturers will need to demonstrate clinically useful outcomes rather than rely exclusively on consumer curiosity if long-term adoption is to remain durable.

Respiratory and Sleep Disease Management

Respiratory and sleep applications include COPD, asthma, sleep apnea, chronic respiratory failure, oxygen dependence, and post-respiratory hospitalization monitoring. Connected respiratory devices allow healthcare professionals and equipment providers to assess therapy use and identify problems without requiring frequent facility visits.

The segment is particularly relevant in rural areas where pulmonary specialists may be distant from patients. Connected respiratory systems can support centralized monitoring across large geographic areas and may help health systems extend scarce clinical resources.

Post-Acute, Transitional, and Hospital-at-Home Care

Post-acute monitoring is one of the fastest-growing applications because U.S. hospitals face both capacity pressure and financial exposure to avoidable readmissions. Patients discharged after heart failure, pneumonia, COPD exacerbations, surgery, infection, or other high-risk episodes may receive connected scales, blood-pressure monitors, oximeters, thermometers, wearable sensors, or multi-parameter devices.

Hospital-at-home requires an even higher level of device reliability because selected patients who would otherwise occupy inpatient beds are receiving care in residential environments. This favors clinically validated devices, cellular connectivity, remote technical support, escalation protocols, and redundant monitoring capabilities.

Elderly Care and Multi-Chronic Disease Management

Older adults frequently live with several simultaneous conditions rather than a single isolated diagnosis. Consequently, elderly-care programs increasingly require multi-parameter monitoring rather than disease-specific devices. Blood pressure, weight, glucose, oxygen saturation, activity, falls, medication adherence, and caregiver alerts may all be relevant for the same patient.

The key commercial opportunity is therefore platform consolidation. Systems that can combine several device types within one patient and clinician experience may be better suited to Medicare Advantage, accountable care, home-based primary care, and senior-living programs than single-device products.

 

By End User

Patients and Households

Patients and households are becoming increasingly important purchasers as over-the-counter access, e-commerce, retail pharmacy distribution, subscription models, and consumer interest in self-monitoring expand. Direct purchase is particularly relevant for blood-pressure monitoring, pulse oximetry, glucose monitoring, sleep technologies, medical alert devices, and selected connected diagnostic tools.

Manufacturers targeting consumers must balance ease of use with regulatory and clinical credibility. Products that generate large amounts of uninterpretable data can create anxiety rather than value. Successful consumer-facing systems will increasingly provide clinically meaningful interpretation and clear pathways for professional follow-up.

Hospitals and Integrated Health Systems

Hospitals and integrated delivery networks are major institutional buyers for connected home healthcare programs. Their use cases include hospital-at-home, readmission reduction, post-surgical surveillance, cardiac and pulmonary monitoring, oncology pathways, and chronic-disease management.

Hospital procurement committees increasingly evaluate connected-home solutions through total program economics. Device price is only one element. Connectivity failure rates, patient onboarding, nurse workload, integration costs, technical support, data security, EHR interoperability, clinical escalation, and patient retention all influence purchasing decisions.

Physician Groups, Specialty Practices, and RPM Providers

Primary-care groups, cardiology practices, endocrinology practices, nephrology groups, pulmonary practices, and dedicated RPM organizations are increasingly important end users because Medicare and commercial reimbursement can support recurring monitoring programs.

These buyers tend to prioritize efficient patient enrollment, automated device logistics, billing support, low staff burden, exception-based dashboards, and scalable patient communication. A low-cost device that creates manual work can have worse economics than a premium device with reliable automatic transmission.

Home Health, Post-Acute, and Senior-Care Providers

Home health agencies, skilled post-acute networks, assisted-living operators, senior-care organizations, and home-based medical groups represent an expanding customer category. Their needs often involve older, medically complex patients with limited technical confidence.

The best devices for these settings require simple onboarding, caregiver access, cellular or passive connectivity, and strong technical support. Technologies that help identify deterioration between scheduled nursing visits can create meaningful clinical value.

Payers, Medicare Advantage Plans, Employers, and Risk-Bearing Organizations

Payers and risk-bearing entities increasingly fund connected monitoring when there is evidence that the program can reduce downstream medical costs. Medicare Advantage plans are particularly relevant because their membership is older and has high chronic-disease prevalence.

Payers generally require stronger economic evidence than individual clinicians. They evaluate patient selection, engagement, intervention frequency, utilization reduction, total cost of care, quality measures, and persistence. Device companies seeking payer contracts therefore need population-health evidence rather than device-performance data alone.

 

By Technology Type

Bluetooth and Bluetooth Low Energy Connected Devices

Bluetooth and BLE remain widely used because smartphones can function as inexpensive data gateways. The architecture is common across CGMs, blood-pressure monitors, ECG devices, pulse oximeters, scales, inhalers, and consumer-accessible medical technologies.

Its main limitation is dependence on patient pairing, smartphone compatibility, application permissions, operating-system updates, and device proximity. Bluetooth works particularly well for digitally confident populations but can create implementation friction in frail elderly cohorts.

Wi-Fi Connected Devices

Wi-Fi supports higher-volume data transfer and can work well for stationary home systems such as sleep therapy devices, diagnostic hubs, multi-parameter monitors, and certain therapeutic equipment. It reduces dependence on continuous smartphone proximity.

However, healthcare organizations cannot assume that every household has stable broadband or that patients can configure networks securely. Enterprise deployment therefore requires fallback strategies and technical support.

Cellular Connected Devices

Cellular connectivity is increasingly favored in provider-managed RPM programs because devices can transmit information without requiring the patient to pair a smartphone or configure home internet. Cellular blood-pressure monitors, scales, hubs, and multi-parameter systems substantially reduce onboarding complexity.

The trade-off is recurring connectivity cost, carrier dependence, and hardware expense. For high-risk Medicare and post-acute patients, however, the reduction in technical failure can justify the additional cost.

Hybrid Gateway and Multi-Device Platforms

Hybrid systems connect multiple peripheral devices through a dedicated hub or tablet and then transmit data using cellular or Wi-Fi networks. These platforms are strategically important for hospital-at-home and multi-chronic-disease management because several medical devices can be managed through one connectivity layer.

Hospitals increasingly prefer these systems when they can reduce device fragmentation, centralize technical support, and feed information into one clinical dashboard.

Cloud-Integrated, Interoperable, and AI-Enabled Device Architectures

Cloud-integrated connected devices represent the highest strategic layer of the market. The device is only the data-acquisition point; the broader commercial value comes from integration, analytics, alert prioritization, patient engagement, and workflow automation.

AI-enabled architectures are expected to grow rapidly through 2035 as providers seek exception-based monitoring rather than manual review of every measurement. Interoperability with EHRs and virtual-care platforms will become a major procurement differentiator.

 

Regional Insights: Where the Market is Growing Fastest

The U.S. Connected Home Healthcare Devices Market is geographically segmented into the Northeast, Midwest, South, and West. Regional performance differs according to age structure, chronic-disease burden, Medicare enrollment, health-system concentration, population growth, broadband access, rurality, technology adoption, home-health utilization, hospital-at-home activity, specialist availability, and payer penetration.

For market-modeling purposes, the South represented the largest regional market in 2025 at approximately USD 10.45 billion, followed by the West at USD 7.15 billion, Northeast at USD 6.10 billion, and Midwest at USD 4.90 billion. The West is expected to record the fastest percentage growth through 2035, while the South should retain the largest absolute revenue pool.

State-level values discussed below are directional analyst allocations within the national model rather than government-reported device-revenue statistics. They are designed to indicate relative commercial opportunity using population, age, chronic-disease burden, provider infrastructure, connected-care maturity, and purchasing intensity.

South

The South is the largest U.S. connected home healthcare device market and accounted for an estimated USD 10.45 billion in 2025. The region is expected to reach approximately USD 34.25 billion by 2035, representing an estimated CAGR of approximately 12.6%.

The South includes Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Alabama, Kentucky, Mississippi, Tennessee, Arkansas, Louisiana, Oklahoma, and Texas. Washington, D.C. also functions as an important adjacent healthcare market within the broader Mid-Atlantic provider ecosystem.

The region combines several conditions favorable to connected home care: rapid population growth, large Medicare populations, high hypertension and diabetes prevalence, substantial rural territory, growing integrated health systems, and expanding home-based healthcare programs.

Texas represents the largest Southern state opportunity, with an estimated 2025 connected-home device market of roughly USD 2.0–2.2 billion within this model. Houston, Dallas-Fort Worth, Austin, and San Antonio contain major health systems, specialty groups, home-health networks, Medicare Advantage populations, and digitally enabled provider organizations. Texas also has large rural areas where remote monitoring can improve access to specialty care.

Florida represents another strategically important market, estimated at approximately USD 1.6–1.8 billion in 2025. Its unusually large older-adult population creates high demand for connected diabetes devices, blood-pressure monitoring, cardiac surveillance, sleep therapy, home safety technologies, and post-acute care. The state is particularly attractive to organizations targeting Medicare Advantage and senior-oriented care models.

North Carolina and Georgia are high-growth markets because of population migration, expanding health-system networks, major academic institutions, and increasing investment in outpatient and home-based care. North Carolina also has strong life-science and healthcare technology infrastructure that can support clinical pilots and commercialization.

Virginia and Maryland benefit from dense provider networks, relatively high household technology use, proximity to federal healthcare activity, and major metropolitan markets. Connected cardiovascular, chronic-care, and post-discharge programs are particularly attractive in Northern Virginia, Richmond, Baltimore, and the Washington metropolitan region.

Tennessee is important because Nashville serves as a major headquarters and operating center for healthcare companies, health systems, home-health providers, and healthcare services organizations. This creates an environment conducive to enterprise deployment of RPM and home-care technologies.

South Carolina, Kentucky, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, and West Virginia present a different opportunity. These states frequently show higher chronic-disease prevalence, more rural healthcare constraints, and lower specialist density. The addressable clinical need is substantial, but adoption depends heavily on affordability, cellular connectivity, reimbursement support, simple patient onboarding, and provider workforce capacity.

Manufacturers entering the Southern market should therefore avoid treating the region as homogeneous. Large metropolitan markets support premium multi-device and hospital-at-home systems, while rural and lower-income markets favor highly automated, low-touch, cellular-enabled monitoring models. The region’s size means that successful national connected-home companies will generally require meaningful distribution and provider relationships across multiple Southern states.

West

The West represented approximately USD 7.15 billion in connected home healthcare device revenue in 2025 and is projected to reach approximately USD 27.75 billion by 2035, implying a CAGR of roughly 14.5%, the fastest among the four major regions.

The West includes Montana, Idaho, Wyoming, Colorado, New Mexico, Arizona, Utah, Nevada, Washington, Oregon, California, Alaska, and Hawaii.

California is the dominant state market and is estimated at approximately USD 3.4–3.6 billion in 2025. The state combines a very large population with advanced academic medical centers, major integrated delivery networks, large Medicaid and Medicare populations, health technology companies, venture investment, device developers, consumer technology platforms, and sophisticated employer health programs.

California is particularly important for early adoption of CGM, wearable cardiovascular technologies, AI-enabled monitoring, virtual specialty care, connected diagnostics, and home-based chronic-disease programs. Health systems in the Bay Area, Los Angeles, San Diego, Sacramento, and Orange County frequently serve as early evaluators of digital and connected medical technologies.

Washington and Oregon are attractive because large integrated health organizations and technology-oriented populations support connected-care models. Washington also benefits from proximity to cloud-computing, consumer technology, and digital-health ecosystems that influence healthcare interoperability and analytics.

Arizona and Nevada are among the fastest-growing state opportunities because of strong population migration and substantial older-adult populations. Demand is especially relevant for diabetes management, hypertension monitoring, cardiac care, sleep therapy, senior safety, and home-based care.

Colorado and Utah are important innovation-oriented markets with relatively high digital adoption, strong health systems, and growing populations. Colorado’s major health networks and technology ecosystem support sophisticated virtual-care deployments, while Utah combines healthcare innovation, medical-device activity, and population growth.

Idaho, Montana, Wyoming, New Mexico, and Alaska have lower absolute device revenue but offer significant need for remote monitoring because geographic distance can limit access to specialist care. Cellular-enabled devices and hub-based monitoring are particularly valuable in these markets, although broadband gaps and logistics can affect adoption.

Hawaii is a small revenue market but strategically relevant for remote monitoring because its island geography creates unique access and transportation constraints. Connected chronic-care and specialty-monitoring technologies can reduce the need for repeated travel between islands or to major medical centers.

The West’s forecast leadership is expected to come from a combination of technology adoption, population growth in Southwestern states, early adoption of AI and connected medical platforms, strong consumer willingness to use digital health tools, and extensive experimentation with new care-delivery models.

Manufacturers competing in the West should expect comparatively high demand for interoperability, user experience, analytics, cybersecurity, and integration with existing digital platforms. Enterprise buyers in this region are less likely to view connectivity alone as product differentiation.

Northeast

The Northeast accounted for approximately USD 6.10 billion in 2025 and is expected to reach about USD 19.15 billion by 2035, representing a CAGR of approximately 12.1%.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, and Pennsylvania.

New York is the largest Northeastern state market and is estimated at approximately USD 1.7–1.8 billion in 2025. Its size is supported by New York City’s large hospital systems, dense specialist networks, academic medicine, major payer populations, and extensive home-care infrastructure. Upstate New York also creates strong use cases for remote monitoring because access conditions differ substantially outside the metropolitan region.

Pennsylvania represents roughly USD 1.0–1.2 billion in modeled 2025 revenue and is supported by large health systems in Philadelphia, Pittsburgh, and other regional centers. The state has substantial cardiovascular, diabetes, respiratory, and aging-related device demand and offers a mix of urban tertiary care and rural monitoring opportunities.

Massachusetts is one of the most influential states despite its smaller population. Boston’s concentration of academic medical centers, biotechnology, digital health, medical-device research, venture investment, and specialist care makes Massachusetts an important clinical-validation market. Novel connected devices often gain credibility through studies, pilots, or clinical adoption at major institutions in the state.

New Jersey provides a strong commercial market because of population density, pharmaceutical and life-science presence, high healthcare spending, and proximity to New York and Philadelphia provider networks. Connected diabetes, cardiology, home respiratory, and senior-care technologies have significant commercial potential.

Connecticut, Rhode Island, New Hampshire, Vermont, and Maine have smaller absolute markets but strong aging-related demand. Northern New England in particular includes rural and older populations that can benefit from remote specialist access and home monitoring. However, scale economics can be more difficult for providers because patients may be geographically dispersed.

Northeast hospital procurement tends to be evidence intensive. Academic centers and large integrated systems frequently demand clinical validation, cybersecurity reviews, integration documentation, privacy controls, workflow studies, and economic evidence before enterprise deployment.

The region is also important for complex-care monitoring. Advanced cardiac populations, oncology programs, transplant centers, specialty pulmonary programs, and academic home-hospital initiatives create opportunities for higher-acuity connected devices rather than only basic chronic-care monitoring.

Growth is expected to remain slightly below the West because several Northeastern states have slower population growth and more mature healthcare markets. However, revenue per enrolled patient can be high because providers frequently deploy advanced devices and clinically sophisticated monitoring pathways.

Midwest

The Midwest represented approximately USD 4.90 billion in 2025 and is forecast to reach approximately USD 14.23 billion by 2035, translating to a CAGR of roughly 11.3%.

The region includes Indiana, Illinois, Michigan, Ohio, Wisconsin, Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.

Illinois is the largest Midwestern state opportunity, estimated at approximately USD 0.8–0.9 billion in 2025. Chicago has a large academic, community-hospital, specialist, employer, and payer ecosystem that supports both high-acuity remote monitoring and broad chronic-disease programs.

Ohio is another major market, with large integrated health systems and nationally recognized medical institutions. The state’s population size, cardiometabolic disease burden, and healthcare infrastructure create demand across connected blood-pressure monitoring, diabetes, cardiac monitoring, respiratory care, and post-discharge programs.

Michigan provides strong opportunity in chronic-disease management and health-system-led connected care. Detroit and surrounding healthcare networks provide substantial patient populations, while rural northern areas support remote-access use cases.

Minnesota has strategic importance beyond its population because it is one of the country’s most established medical-device centers. The presence of medtech expertise, large health systems, and a sophisticated insurance environment makes the state influential in connected-device development, clinical evaluation, and commercialization.

Wisconsin, Indiana, and Missouri represent stable mid-sized markets with substantial hospital and outpatient infrastructure. Connected devices are increasingly relevant as providers attempt to manage chronic diseases while limiting unnecessary utilization.

Iowa, Kansas, Nebraska, North Dakota, and South Dakota have smaller populations but strong practical use cases for telehealth and remote monitoring because many patients live far from tertiary medical centers. Cellular connectivity and simplified logistics are important competitive attributes in these states.

The Midwest is expected to grow more slowly than the West and South but remains commercially attractive because healthcare organizations often value measurable operational efficiency, product reliability, service support, and cost control. Manufacturers with strong enterprise account management and durable provider relationships can build significant recurring revenue.

For the region overall, rural healthcare economics will be a major market determinant. Connected devices can reduce travel and improve monitoring, but provider staffing remains a bottleneck. Technologies that automate enrollment, transmission, triage, documentation, and patient outreach will therefore be more valuable than systems that simply generate additional clinical data.

 

Key Market Players

The U.S. Connected Home Healthcare Devices Competitive Landscape is fragmented across diabetes technology, cardiovascular monitoring, respiratory care, home patient monitoring, wearable sensors, home diagnostics, medical alert systems, and virtual-care infrastructure.

Unlike conventional device markets in which several companies compete within one product category, connected home healthcare involves overlapping ecosystems. A health system may simultaneously contract with one vendor for CGM, another for cardiac patches, another for respiratory therapy, and a fourth provider for an integrated RPM platform. Competition is therefore increasingly based on the ability to control high-value disease pathways and integrate into broader home-care programs.

Some of the key participants in the U.S. Connected Home Healthcare Devices industry include:

Abbott Laboratories
Dexcom
Medtronic
Insulet Corporation
Tandem Diabetes Care
ResMed
Philips Healthcare
GE HealthCare
Baxter International
Masimo
OMRON Healthcare
iRhythm Technologies
Boston Scientific Corporation
AliveCor
BioIntelliSense
VitalConnect
Current Health / Best Buy Health
TytoCare
Eko Health
Withings Health Solutions
ZOLL Medical
BIOTRONIK
Roche Diabetes Care
Ascensia Diabetes Care
LifeScan

Abbott and Dexcom hold particularly strong positions in continuous glucose monitoring, one of the industry’s largest recurring-revenue categories. Medtronic, Insulet, and Tandem Diabetes Care add connected insulin-delivery and diabetes-therapy capabilities.

ResMed and Philips are influential in home respiratory and sleep therapy, where cloud-connected equipment has become central to adherence monitoring and long-term disease management.

iRhythm, AliveCor, VitalConnect, BioIntelliSense, ZOLL, BIOTRONIK, Boston Scientific, and other cardiovascular monitoring companies compete across wearable ECG, ambulatory rhythm monitoring, connected implants, multiparameter sensing, and remote cardiac management.

OMRON is strongly positioned in home blood-pressure monitoring, while Masimo, Baxter, GE HealthCare, and Philips can leverage broader hospital monitoring relationships as care moves beyond the hospital.

Current Health, TytoCare, BioIntelliSense, and similar platforms are strategically important because they address higher-acuity home monitoring and virtual-care deployment rather than only one disease category. Their opportunity increases as hospitals attempt to extend clinical infrastructure into residential environments.

Over the forecast period, competition will increasingly be shaped by interoperability, data rights, recurring consumables, clinical evidence, cybersecurity, reimbursement support, patient engagement, logistics, and the ability to reduce clinician workload.

Device companies with large installed bases will attempt to move vertically into software and monitoring. Digital-health companies will move in the opposite direction by incorporating proprietary or third-party medical devices. Health systems will favor platforms that reduce the number of separate contracts, dashboards, and integrations required to manage home-based patients.

 

Recent Developments

Recent developments in the U.S. Connected Home Healthcare Devices Market demonstrate that home-based medical technology is entering a new regulatory and commercial phase.

One of the most important shifts has been the expansion of continuous glucose monitoring beyond conventional prescription populations. In 2024, the first over-the-counter CGM received U.S. clearance, followed by additional OTC glucose-monitoring products. The development effectively opened a new retail and direct-to-consumer channel for a technology previously concentrated primarily in diabetes treatment.

CGM innovation continued through longer wear times, smaller sensors, improved smartphone integration, and additional regulatory clearances. These developments reinforce the position of glucose monitoring as one of the most dynamic connected-device markets in the United States.

Remote patient monitoring reimbursement has also continued to evolve. Medicare payments for RPM exceeded USD 500 million in 2024, demonstrating significant provider adoption. For 2026, Medicare’s remote-monitoring framework includes device data-collection pathways based on shorter 2–15-day and longer 16-plus-day monitoring periods depending on the applicable code, creating more flexibility for selected use cases.

At the same time, regulators are focusing more closely on program integrity. Proposed Medicare policy changes for 2027 would tighten aspects of remote monitoring, including practitioner relationships, initiating visits, and the use of contracted clinical staff. These proposals are not final as of August 2026, but they highlight an important market risk: RPM business models built primarily around outsourced billing economics may face greater scrutiny than programs embedded within genuine longitudinal clinical care.

Hospital-at-home received an important policy extension, with the federal Acute Hospital Care at Home framework extended through September 30, 2030. This gives hospitals a longer strategic horizon for developing home-based acute-care infrastructure and supports demand for reliable multiparameter monitoring, connected diagnostics, remote communication, and home-care logistics.

The FDA is also making home-based care a more explicit medical-device priority. Its Home as a Health Care Hub initiative encourages manufacturers to design technologies for integrated use within residential environments rather than simply relocating hospital devices into homes.

In 2026, the FDA launched the READI-Home Innovation Challenge to accelerate medical-device technologies intended to reduce avoidable hospital readmissions. This is strategically important because post-discharge monitoring is one of the largest potential growth pools for connected home devices.

Cybersecurity has become another defining development. Updated FDA cybersecurity expectations require manufacturers of connected medical devices to treat software security as a lifecycle responsibility. Hospitals are consequently incorporating cybersecurity assessments more deeply into procurement.

The competitive environment is also moving toward platform consolidation. Device manufacturers are integrating cloud dashboards, analytics, patient engagement, and clinical decision support, while virtual-care organizations are adding device logistics and remote monitoring. The long-term competitive boundary between medical devices, digital health, home health, and care-management platforms is therefore becoming increasingly blurred.

 

Conclusion

The U.S. Connected Home Healthcare Devices Market Size & Share is positioned for substantial expansion from approximately USD 28.60 billion in 2025 to USD 95.38 billion by 2035, representing a CAGR of 12.80% during 2026–2035.

The market’s long-term growth is supported by durable structural forces rather than a temporary telehealth cycle. These include the scale of chronic disease, an aging population, greater patient acceptance of health technology, Medicare remote-monitoring economics, provider pressure to reduce hospitalization, growth of value-based care, increasing hospital-at-home activity, and continuing advances in medical sensors and wireless connectivity.

The largest revenue pools will remain connected diabetes management, cardiovascular monitoring, hypertension management, respiratory and sleep therapy, and multiparameter chronic-disease monitoring. The fastest emerging opportunities will include higher-acuity post-discharge monitoring, hospital-at-home devices, passive sensing, AI-driven clinical triage, integrated multi-device home platforms, and technologies designed specifically for aging populations.

The market will nevertheless become more demanding. Healthcare buyers are moving beyond enthusiasm for remote care and increasingly requiring evidence of measurable economic and clinical value. Connected devices that create additional nurse workload, generate excessive alerts, fail to integrate with EHRs, or require complex patient troubleshooting will struggle to scale even when their underlying sensors perform well.

Hospital procurement decisions will increasingly evaluate the complete cost of managing a connected patient. Important variables will include device acquisition, sensors and consumables, connectivity, provisioning, technical support, patient adherence, clinician time, software fees, integration, cybersecurity, reimbursement, and the downstream effect on hospital utilization.

The regional opportunity will remain led by the South because of population scale, chronic-disease burden, aging demographics, and growing healthcare networks. The West is expected to show the fastest growth as connected-care innovation, AI adoption, consumer technology familiarity, and population expansion converge. The Northeast will remain highly influential in clinical validation and advanced home-care models, while the Midwest will provide a stable market built around mature provider networks and strong rural-monitoring use cases.

At the state level, California, Texas, Florida, New York, Pennsylvania, Illinois, Ohio, Massachusetts, North Carolina, Georgia, Arizona, Washington, Michigan, Minnesota, Virginia, and New Jersey represent particularly important commercial markets, although rural states create disproportionate demand for technologies capable of overcoming specialist-access limitations.

For manufacturers, investors, providers, payers, distributors, and technology companies evaluating this market, the central strategic question is not whether more healthcare will move into the home. That transition is already occurring. The more important questions are which device categories will become embedded in standard clinical pathways, which reimbursement structures will prove durable, which technologies can reduce rather than increase clinician workload, and which companies can integrate hardware, connectivity, analytics, cybersecurity, and clinical evidence into a coherent home-care platform.

The next decade of the U.S. connected home healthcare devices industry will therefore be defined by the transition from connected products to connected care infrastructure. Companies that simply transmit data will face increasing commoditization. Companies that help U.S. healthcare organizations identify risk earlier, manage more patients with limited labor, prevent avoidable utilization, and safely extend clinical care into the home will be positioned to capture the highest-value opportunities through 2035.

 

TABLE OF CONTENT

1. U.S. Connected Home Healthcare Devices Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Analytical Frameworks & Forecasting Models
1.3.6. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Connected Home Healthcare Device Manufacturers
1.6.2. Sensors, Semiconductors, Connectivity and Component Suppliers
1.6.3. Hospitals and Integrated Delivery Networks
1.6.4. Physician Groups, Specialty Practices and Remote Monitoring Providers
1.6.5. Home Health, Post-Acute and Senior-Care Providers
1.6.6. Pharmacies, DME Suppliers, Distributors and Retail Channels
1.6.7. Medicare, Medicaid, Commercial Payers and Medicare Advantage Plans
1.6.8. Patients, Family Caregivers and Home-Based Care Consumers
1.6.9. FDA, CMS and Other Regulatory Stakeholders

What this section provides: This section defines the market boundary, covered connected medical-device categories, study methodology, core assumptions, and stakeholder ecosystem so clients understand precisely how the U.S. Connected Home Healthcare Devices Market is measured, segmented, and validated.

2. U.S. Connected Home Healthcare Devices Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size & Growth Opportunity, 2025–2035
2.8. Fastest-Growing Device Categories
2.9. High-Growth Clinical Applications
2.10. Priority State-Level Opportunity Markets
2.11. Strategic Opportunity Areas for Manufacturers and Investors

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, connected-care adoption, leading device categories, priority clinical applications, regional opportunities, competitive intensity, and the most attractive investment areas.

3. U.S. Connected Home Healthcare Devices Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Rising U.S. Chronic Disease and Multi-Morbidity Burden
3.1.2. Rapid Growth of the U.S. Population Aged 65 and Older
3.1.3. Expansion of Remote Physiologic Monitoring Adoption
3.1.4. Medicare and Commercial Payer Support for Remote Monitoring
3.1.5. Growth of Hospital-at-Home and Higher-Acuity Home Care
3.1.6. Expansion of Connected Diabetes and Continuous Glucose Monitoring
3.1.7. Increasing Adoption of Connected Cardiac Monitoring
3.1.8. Shift Toward Aging-in-Place and Home-Based Chronic Care
3.1.9. Increasing Smartphone and Digital Health Adoption Among Older Adults
3.1.10. Provider Focus on Avoidable Hospitalization and Readmission Reduction
3.2. Restraints and Their Impact Analysis
3.2.1. Fragmented Reimbursement and Changing RPM Billing Requirements
3.2.2. Patient Digital Literacy and Device Engagement Limitations
3.2.3. Cybersecurity and Patient Data Privacy Concerns
3.2.4. Device Connectivity and Interoperability Limitations
3.2.5. Clinician Alert Fatigue and Workflow Burden
3.2.6. Device Affordability and Out-of-Pocket Cost Barriers
3.2.7. Broadband and Cellular Access Gaps in Rural Communities
3.3. Opportunities and Their Impact Analysis
3.3.1. Continuous Glucose Monitoring Expansion Beyond Insulin-Intensive Diabetes
3.3.2. Multi-Parameter Remote Monitoring Platforms
3.3.3. Wearable ECG and Long-Term Cardiac Monitoring
3.3.4. Post-Discharge and Transitional Care Monitoring
3.3.5. Hospital-at-Home Device Infrastructure
3.3.6. Connected Respiratory and Sleep Therapy
3.3.7. Passive Monitoring and Aging-in-Place Technologies
3.3.8. AI-Based Clinical Triage and Predictive Monitoring
3.3.9. Cellular-Enabled Devices for High-Risk and Elderly Populations
3.3.10. Medicare Advantage and Value-Based Care Partnerships
3.4. Challenges and Their Impact Analysis
3.4.1. Scaling Remote Monitoring Without Increasing Clinical Labor
3.4.2. Maintaining Long-Term Patient Adherence
3.4.3. Managing Multiple Devices and Data Streams
3.4.4. Demonstrating Measurable Clinical and Economic Outcomes
3.4.5. Technology Obsolescence and Device Replacement Cycles
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.7. Health System Procurement and Vendor Evaluation Analysis
3.8. Remote Monitoring Program Economics
3.9. Patient Acquisition, Activation and Retention Economics

What this section provides: This section evaluates the clinical, demographic, reimbursement, technological, behavioral, and economic forces influencing connected home healthcare device demand and helps clients assess both market upside and implementation risk.

4. U.S. Connected Home Healthcare Devices Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. Medical Sensor and Semiconductor Supply Landscape
4.6. Device Connectivity and Data Transmission Ecosystem
4.7. Interoperability, APIs and EHR Integration Landscape
4.8. Artificial Intelligence and Predictive Analytics Impact
4.9. FDA Regulatory Framework for Connected and Home-Use Medical Devices
4.10. FDA Cybersecurity Requirements and Postmarket Device Security
4.11. CMS Remote Physiologic Monitoring Reimbursement Landscape
4.12. CMS Remote Therapeutic Monitoring Reimbursement Landscape
4.13. Medicare Advantage and Commercial Payer Coverage Environment
4.14. Hospital-at-Home Regulatory and Payment Landscape
4.15. HIPAA, Privacy and Connected Health Data Considerations
4.16. Import/Export Restrictions & Tariff Impact
4.17. Government Initiatives Supporting Home-Based Healthcare
4.18. Impact of Escalating Geopolitical and Supply-Chain Tensions
4.19. Health System Value Analysis and Digital Technology Decision Framework

What this section provides: This section gives clients a complete assessment of the U.S. connected-home healthcare environment, including regulation, reimbursement, cybersecurity, interoperability, pricing, supply chain, payer behavior, technology adoption, and enterprise procurement requirements.

5. U.S. Connected Home Healthcare Devices Market – By Product Category

5.1. Overview
5.1.1. Segment Share Analysis, By Product Category, 2025 & 2035 (%)
5.1.2. Connected Physiological Monitoring Devices
5.1.2.1. Connected Blood Pressure Monitors
5.1.2.2. Connected Pulse Oximeters
5.1.2.3. Connected Weight Scales
5.1.2.4. Connected ECG and Cardiac Monitoring Devices
5.1.2.5. Connected Thermometers
5.1.2.6. Multi-Parameter Vital Sign Monitors
5.1.3. Connected Diabetes Management Devices
5.1.3.1. Continuous Glucose Monitoring Systems
5.1.3.2. Connected Blood Glucose Meters
5.1.3.3. Connected Insulin Pumps
5.1.3.4. Automated Insulin Delivery Systems
5.1.3.5. Smart and Connected Insulin Pens
5.1.4. Connected Respiratory and Sleep Therapy Devices
5.1.4.1. Connected CPAP Devices
5.1.4.2. Connected BiPAP Devices
5.1.4.3. Connected Home Ventilation Systems
5.1.4.4. Connected Oxygen Therapy and Monitoring Devices
5.1.4.5. Connected Inhalers
5.1.4.6. Home Spirometry and Pulmonary Monitoring Devices
5.1.5. Connected Medication and Therapy Adherence Devices
5.1.5.1. Smart Medication Dispensers
5.1.5.2. Connected Pill Containers
5.1.5.3. Electronic Medication Adherence Devices
5.1.5.4. Connected Drug Delivery and Injection Support Devices
5.1.5.5. Therapy Compliance Monitoring Systems
5.1.6. Connected Safety, Aging-in-Place and Post-Acute Devices
5.1.6.1. Personal Emergency Response Systems
5.1.6.2. Fall Detection Devices
5.1.6.3. Activity and Mobility Monitoring Devices
5.1.6.4. Ambient and Passive Home Monitoring Systems
5.1.6.5. Connected Home Diagnostic Devices
5.1.6.6. Post-Acute Multi-Parameter Monitoring Kits

What this section provides: This section identifies the connected home healthcare device categories generating the largest revenue pools and evaluates which technologies are expected to deliver the strongest growth through 2035.

6. U.S. Connected Home Healthcare Devices Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Cardiovascular Disease and Hypertension Management
6.1.2.1. Hypertension Monitoring
6.1.2.2. Heart Failure Monitoring
6.1.2.3. Arrhythmia Detection and Monitoring
6.1.2.4. Post-Cardiac Procedure Monitoring
6.1.3. Diabetes and Metabolic Disease Management
6.1.3.1. Type 1 Diabetes Management
6.1.3.2. Type 2 Diabetes Management
6.1.3.3. Insulin Therapy Optimization
6.1.3.4. Metabolic Health and Glucose Trend Monitoring
6.1.4. Respiratory and Sleep Disease Management
6.1.4.1. Obstructive Sleep Apnea
6.1.4.2. Chronic Obstructive Pulmonary Disease
6.1.4.3. Asthma Management
6.1.4.4. Chronic Respiratory Failure
6.1.4.5. Home Oxygen and Ventilation Monitoring
6.1.5. Post-Acute, Transitional and Hospital-at-Home Care
6.1.5.1. Hospital Discharge Monitoring
6.1.5.2. Readmission Prevention
6.1.5.3. Post-Surgical Monitoring
6.1.5.4. Acute Hospital Care at Home
6.1.5.5. Home-Based Specialty Care
6.1.6. Elderly Care and Multi-Chronic Disease Management
6.1.6.1. Aging-in-Place Monitoring
6.1.6.2. Multi-Morbidity Management
6.1.6.3. Fall Risk and Mobility Monitoring
6.1.6.4. Medication Adherence Monitoring
6.1.6.5. Caregiver-Supported Home Monitoring

What this section provides: This section helps clients understand demand by clinical use case and identify applications where chronic-disease prevalence, reimbursement potential, avoidable utilization, home-care migration, and connected-device innovation create the strongest commercial opportunity.

7. U.S. Connected Home Healthcare Devices Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Patients and Households
7.1.2.1. Prescription Device Users
7.1.2.2. Over-the-Counter Connected Device Users
7.1.2.3. Family Caregiver-Supported Patients
7.1.3. Hospitals and Integrated Health Systems
7.1.3.1. Hospital-at-Home Programs
7.1.3.2. Transitional Care Programs
7.1.3.3. Population Health and Chronic Care Programs
7.1.3.4. Virtual Nursing and Home Monitoring Programs
7.1.4. Physician Groups, Specialty Practices and RPM Providers
7.1.4.1. Primary Care Practices
7.1.4.2. Cardiology Practices
7.1.4.3. Endocrinology and Diabetes Practices
7.1.4.4. Pulmonology and Sleep Practices
7.1.4.5. Dedicated Remote Monitoring Providers
7.1.5. Home Health, Post-Acute and Senior-Care Providers
7.1.5.1. Home Health Agencies
7.1.5.2. Home-Based Primary Care Providers
7.1.5.3. Skilled Nursing and Post-Acute Networks
7.1.5.4. Assisted Living and Senior-Care Organizations
7.1.6. Payers and Risk-Bearing Organizations
7.1.6.1. Medicare Advantage Plans
7.1.6.2. Commercial Health Plans
7.1.6.3. Accountable Care Organizations
7.1.6.4. Value-Based Provider Groups
7.1.6.5. Self-Insured Employers

What this section provides: This section identifies the customer groups driving device adoption and evaluates how purchasing criteria differ among patients, health systems, physicians, RPM companies, home-care providers, payers, and risk-bearing organizations.

8. U.S. Connected Home Healthcare Devices Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. Bluetooth and Bluetooth Low Energy Connected Devices
8.1.2.1. Smartphone-Paired Medical Devices
8.1.2.2. Application-Based Device Connectivity
8.1.2.3. Bluetooth-Enabled Wearable Medical Devices
8.1.3. Wi-Fi Connected Devices
8.1.3.1. Home Network-Connected Monitoring Devices
8.1.3.2. Wi-Fi Connected Respiratory and Sleep Systems
8.1.3.3. Home Diagnostic and Monitoring Hubs
8.1.4. Cellular Connected Devices
8.1.4.1. Cellular Blood Pressure Monitors
8.1.4.2. Cellular Connected Weight Scales
8.1.4.3. Cellular Monitoring Hubs
8.1.4.4. Cellular Multi-Parameter Devices
8.1.5. Hybrid Gateway and Multi-Device Platforms
8.1.5.1. Dedicated Home Monitoring Hubs
8.1.5.2. Tablet-Based Monitoring Systems
8.1.5.3. Hospital-at-Home Device Gateways
8.1.5.4. Multi-Device Chronic Care Platforms
8.1.6. Cloud-Integrated, Interoperable and AI-Enabled Device Architectures
8.1.6.1. Cloud-Connected Medical Devices
8.1.6.2. EHR-Integrated Connected Devices
8.1.6.3. API-Enabled Medical Device Platforms
8.1.6.4. AI-Assisted Monitoring and Risk Stratification
8.1.6.5. Predictive Clinical Alert Systems

What this section provides: This section evaluates the connectivity architectures and technology platforms shaping the market, including Bluetooth, Wi-Fi, cellular, multi-device gateway, cloud, interoperability, and AI-enabled connected healthcare environments.

9. U.S. Connected Home Healthcare Devices Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Enterprise Connected Care Contracts
9.1.2.2. Hospital-at-Home Device Procurement
9.1.2.3. Population Health Monitoring Contracts
9.1.3. Physician Group, RPM Provider and Payer Contracts
9.1.3.1. Physician Practice Procurement
9.1.3.2. Remote Patient Monitoring Provider Contracts
9.1.3.3. Medicare Advantage and Health Plan Contracts
9.1.3.4. Value-Based Care Organization Contracts
9.1.4. DME, Home Health and Specialty Distribution
9.1.4.1. Durable Medical Equipment Suppliers
9.1.4.2. Home Health Distribution
9.1.4.3. Specialty Medical Device Distributors
9.1.4.4. Sleep and Respiratory Therapy Providers
9.1.5. Retail Pharmacy and E-Commerce
9.1.5.1. National Pharmacy Chains
9.1.5.2. Medical Supply Retailers
9.1.5.3. Online Healthcare Marketplaces
9.1.5.4. Manufacturer E-Commerce Channels
9.1.6. Direct-to-Consumer and Subscription Channels
9.1.6.1. Manufacturer Direct Sales
9.1.6.2. Consumer Subscription Models
9.1.6.3. Over-the-Counter Connected Medical Devices
9.1.6.4. Employer-Sponsored Device Programs

What this section provides: This section explains how connected home healthcare devices reach U.S. patients and healthcare organizations, including health-system procurement, RPM contracts, payer programs, DME distribution, retail pharmacy, e-commerce, and direct-to-consumer channels.

10. U.S. Connected Home Healthcare Devices Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Chronic Disease and Aging Population Analysis
10.1.4. Regional Remote Patient Monitoring Adoption Analysis
10.1.5. Regional Hospital-at-Home and Home Health Infrastructure Analysis
10.1.6. Regional Medicare Advantage and Payer Dynamics
10.1.7. Regional Connectivity, Broadband and Digital Access Analysis
10.1.8. Regional Procurement and Connected-Care Adoption Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Connected Home Healthcare Device Key Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Connected Home Healthcare Device Key Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Connected Home Healthcare Device Key Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Connected Home Healthcare Device Key Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Category, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed four-region and 50-state market intelligence, allowing clients to compare market size, growth outlook, connected-care adoption, chronic-disease demand, aging demographics, reimbursement conditions, technology infrastructure, and state-level commercial opportunities.

11. U.S. Connected Home Healthcare Devices Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Intensity Analysis
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Competitive Benchmarking
11.4.1. Product Portfolio Breadth
11.4.2. Connected Device Installed Base
11.4.3. Recurring Sensor and Consumables Revenue
11.4.4. Provider and Payer Relationships
11.4.5. EHR and Platform Integration
11.4.6. Clinical Evidence and Regulatory Positioning
11.4.7. Artificial Intelligence and Analytics Capability
11.4.8. U.S. Distribution and Commercial Reach
11.5. Company Profiles
11.5.1. Abbott Laboratories
11.5.2. Dexcom, Inc.
11.5.3. Medtronic plc
11.5.4. Insulet Corporation
11.5.5. Tandem Diabetes Care, Inc.
11.5.6. ResMed Inc.
11.5.7. Philips Healthcare
11.5.8. GE HealthCare
11.5.9. Baxter International Inc.
11.5.10. Masimo Corporation
11.5.11. OMRON Healthcare
11.5.12. iRhythm Technologies, Inc.
11.5.13. Boston Scientific Corporation
11.5.14. AliveCor, Inc.
11.5.15. BioIntelliSense, Inc.
11.5.16. VitalConnect, Inc.
11.5.17. Current Health / Best Buy Health
11.5.18. TytoCare Ltd.
11.5.19. Eko Health, Inc.
11.5.20. Withings Health Solutions
11.5.21. ZOLL Medical Corporation
11.5.22. BIOTRONIK
11.5.23. Roche Diabetes Care
11.5.24. Ascensia Diabetes Care
11.5.25. LifeScan, Inc.
11.6. Company Profile Parameters
11.6.1. Company Overview
11.6.2. Connected Home Healthcare Device Portfolio
11.6.3. U.S. Market Strategy
11.6.4. Financial Positioning
11.6.5. Product Innovation Pipeline
11.6.6. FDA and Regulatory Updates
11.6.7. Clinical Evidence and Key Studies
11.6.8. Partnerships and Health System Collaborations
11.6.9. Mergers, Acquisitions and Strategic Investments
11.6.10. Recent Developments

What this section provides: This section gives clients competitor benchmarking, market-share visibility, portfolio positioning, connected-care capabilities, clinical and regulatory intelligence, partnership analysis, and strategic insight into the major companies shaping the U.S. Connected Home Healthcare Devices Market.

12. U.S. Connected Home Healthcare Devices Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Next-Generation Continuous Biosensing
12.2.2. Artificial Intelligence and Predictive Deterioration Detection
12.2.3. Passive and Ambient Home Monitoring
12.2.4. Connected Multi-Parameter Wearables
12.2.5. Automated Insulin Delivery and Next-Generation CGM
12.2.6. Smartphone-Based Medical Diagnostics
12.2.7. Voice, Ambient and Sensor-Based Aging-in-Place Technologies
12.2.8. Interoperable Home Medical Device Platforms
12.2.9. Cellular and Low-Power Connected Medical Devices
12.2.10. Hospital-at-Home Monitoring Infrastructure
12.3. Emerging Business Trends
12.3.1. Transition from Device Sales to Recurring Connected-Care Revenue
12.3.2. Hardware-Software-Service Bundling
12.3.3. Expansion of Over-the-Counter Medical Devices
12.3.4. Payer-Device Manufacturer Partnerships
12.3.5. Provider Consolidation of Remote Monitoring Vendors
12.3.6. Consumerization of Regulated Medical Technology
12.3.7. Shift Toward Exception-Based Clinical Monitoring
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Product Category Opportunity Matrix
12.7. Clinical Application Opportunity Matrix
12.8. State-Level Market Opportunity Matrix
12.9. Technology Adoption Roadmap, 2026–2035
12.10. Potential Market Disruptors Through 2035

What this section provides: This section prepares clients for future changes in device technology, reimbursement, care delivery, competitive structure, business models, and investment opportunities while defining the innovations most likely to influence the market through 2035.

13. U.S. Connected Home Healthcare Devices Market: Strategic Recommendations

13.1. Recommendations for Connected Medical Device Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Physician Groups and RPM Providers
13.4. Recommendations for Home Health and Post-Acute Providers
13.5. Recommendations for Medicare Advantage and Commercial Payers
13.6. Recommendations for Investors and Private Equity Firms
13.7. Recommendations for Distributors, DME Providers and Retail Channels
13.8. Recommendations for New Entrants and Startups
13.9. U.S. Go-to-Market Strategy Considerations
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. Reimbursement and Market Access Strategy
13.12. Provider Partnership Strategy
13.13. Patient Engagement and Retention Strategy
13.14. Pricing and Contracting Strategy
13.15. Interoperability and EHR Integration Strategy
13.16. Cybersecurity and Regulatory Readiness Strategy
13.17. Regional and State-Level Commercial Prioritization

What this section provides: This section converts market intelligence into actionable recommendations for product development, commercialization, reimbursement, provider contracting, investment, channel expansion, geographic prioritization, and sustainable competitive differentiation in the U.S. connected home healthcare ecosystem.

14. U.S. Connected Home Healthcare Devices Market: Disclaimer

14.1. Scope Limitation
14.2. Market Definition and Inclusion/Exclusion Limitation
14.3. Data Use Limitation
14.4. Primary and Secondary Research Limitation
14.5. Market Estimation Limitation
14.6. Forecasting Limitation
14.7. Regulatory and Reimbursement Change Limitation
14.8. Company and Competitive Intelligence Limitation
14.9. Legal Disclaimer
14.10. Third-Party Data Disclaimer

What this section provides: This section clarifies the report’s scope, market-definition boundaries, estimation methodology limitations, forecasting assumptions, regulatory and reimbursement uncertainty, third-party data usage, and legal conditions governing interpretation of the study.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Connected Home Healthcare Devices Market: Market Definition and Scope
TABLE 3: U.S. Connected Home Healthcare Devices Market: Research Methodology Framework
TABLE 4: U.S. Connected Home Healthcare Devices Market: Key Assumptions
TABLE 5: U.S. Connected Home Healthcare Devices Market: Market Ecosystem Overview
TABLE 6: U.S. Connected Home Healthcare Devices Market: Stakeholder Analysis
TABLE 7: U.S. Connected Home Healthcare Devices Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Connected Home Healthcare Devices Market: Analyst Viewpoint Summary
TABLE 9: U.S. Connected Home Healthcare Devices Market: Market Attractiveness Index
TABLE 10: U.S. Connected Home Healthcare Devices Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Connected Home Healthcare Devices Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Connected Home Healthcare Devices Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Connected Home Healthcare Devices Market: Drivers & Impact Analysis
TABLE 14: U.S. Connected Home Healthcare Devices Market: Restraints & Impact Analysis
TABLE 15: U.S. Connected Home Healthcare Devices Market: Opportunities & Impact Analysis
TABLE 16: U.S. Connected Home Healthcare Devices Market: Challenges & Impact Analysis
TABLE 17: U.S. Connected Home Healthcare Devices Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Connected Home Healthcare Devices Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Connected Home Healthcare Devices Market: Health System Procurement Behavior Matrix
TABLE 20: U.S. Connected Home Healthcare Devices Market: RPM Program Economics Analysis
TABLE 21: U.S. Connected Home Healthcare Devices Market: Patient Activation and Retention Economics
TABLE 22: U.S. Connected Home Healthcare Devices Market: PESTEL Analysis
TABLE 23: U.S. Connected Home Healthcare Devices Market: Porter’s Five Forces Analysis
TABLE 24: U.S. Connected Home Healthcare Devices Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 25: U.S. Connected Home Healthcare Devices Market: Value Chain Analysis
TABLE 26: U.S. Connected Home Healthcare Devices Market: Supply Chain Analysis
TABLE 27: U.S. Connected Home Healthcare Devices Market: Sensor and Semiconductor Supply Landscape
TABLE 28: U.S. Connected Home Healthcare Devices Market: Connectivity and Data Transmission Ecosystem
TABLE 29: U.S. Connected Home Healthcare Devices Market: Interoperability and EHR Integration Landscape
TABLE 30: U.S. Connected Home Healthcare Devices Market: AI and Predictive Analytics Impact
TABLE 31: U.S. Connected Home Healthcare Devices Market: FDA Regulatory Framework Analysis
TABLE 32: U.S. Connected Home Healthcare Devices Market: Cybersecurity and Data Privacy Framework
TABLE 33: U.S. Connected Home Healthcare Devices Market: CMS RPM and RTM Reimbursement Landscape
TABLE 34: U.S. Connected Home Healthcare Devices Market: Hospital-at-Home Policy and Payment Landscape
TABLE 35: U.S. Connected Home Healthcare Devices Market: Government Initiatives and Home-Based Care Programs
TABLE 36: U.S. Connected Home Healthcare Devices Market: Product Category Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Category
TABLE 38: U.S. Connected Home Healthcare Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 39: U.S. Connected Home Healthcare Devices Market: Segment Share Analysis, by Product Category, 2025 & 2035 (%)
TABLE 40: Connected Physiological Monitoring Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: Connected Diabetes Management Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: Connected Respiratory and Sleep Therapy Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Connected Medication and Therapy Adherence Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Connected Safety, Aging-in-Place and Post-Acute Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Connected Home Healthcare Devices Market: Application Snapshot, 2025
TABLE 46: Segment Dashboard; Definition and Scope, by Application
TABLE 47: U.S. Connected Home Healthcare Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 48: U.S. Connected Home Healthcare Devices Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 49: Cardiovascular Disease and Hypertension Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: Diabetes and Metabolic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Respiratory and Sleep Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Post-Acute, Transitional and Hospital-at-Home Care Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Elderly Care and Multi-Chronic Disease Management Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Connected Home Healthcare Devices Market: End User Snapshot, 2025
TABLE 55: Segment Dashboard; Definition and Scope, by End User
TABLE 56: U.S. Connected Home Healthcare Devices Market, by End User, 2021–2035 (US$ Billion)
TABLE 57: U.S. Connected Home Healthcare Devices Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 58: Patients and Households Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 59: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Physician Groups, Specialty Practices and RPM Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Home Health, Post-Acute and Senior-Care Providers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Payers and Risk-Bearing Organizations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Connected Home Healthcare Devices Market: Technology Type Snapshot, 2025
TABLE 64: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 65: U.S. Connected Home Healthcare Devices Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 66: U.S. Connected Home Healthcare Devices Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 67: Bluetooth and Bluetooth Low Energy Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: Wi-Fi Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 69: Cellular Connected Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 70: Hybrid Gateway and Multi-Device Platforms Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 71: Cloud-Integrated, Interoperable and AI-Enabled Device Architectures Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: U.S. Connected Home Healthcare Devices Market: Procurement Channel Snapshot, 2025
TABLE 73: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 74: U.S. Connected Home Healthcare Devices Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 75: U.S. Connected Home Healthcare Devices Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 76: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: Physician Group, RPM Provider and Payer Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: DME, Home Health and Specialty Distribution Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 79: Retail Pharmacy and E-Commerce Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: Direct-to-Consumer and Subscription Channels Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: U.S. Connected Home Healthcare Devices Market: Regional Snapshot, 2025
TABLE 82: Segment Dashboard; Definition and Scope, by Region
TABLE 83: U.S. Connected Home Healthcare Devices Market, by Region, 2021–2035 (US$ Billion)
TABLE 84: U.S. Connected Home Healthcare Devices Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 85: U.S. Connected Home Healthcare Devices Market: Regional Chronic Disease and Aging Population Analysis
TABLE 86: U.S. Connected Home Healthcare Devices Market: Regional RPM and Hospital-at-Home Adoption Analysis
TABLE 87: West Region U.S. Connected Home Healthcare Devices Market: Regional Overview and Trends
TABLE 88: West Region U.S. Connected Home Healthcare Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 89: West Region U.S. Connected Home Healthcare Devices Market, by Product Category, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Connected Home Healthcare Devices Market, by Application, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Connected Home Healthcare Devices Market, by End User and Technology Type, 2021–2035 (US$ Billion)
TABLE 92: California Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Washington Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Arizona Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Colorado Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Oregon Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Utah Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Nevada Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: New Mexico Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Idaho Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Montana Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Wyoming Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Alaska Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Hawaii Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Northeast Region U.S. Connected Home Healthcare Devices Market: Regional Overview and Trends
TABLE 106: Northeast Region U.S. Connected Home Healthcare Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 107: Northeast Region U.S. Connected Home Healthcare Devices Market, by Product Category and Application, 2021–2035 (US$ Billion)
TABLE 108: Northeast Region U.S. Connected Home Healthcare Devices Market, by End User and Technology Type, 2021–2035 (US$ Billion)
TABLE 109: New York Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 110: Massachusetts Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: New Jersey Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: Pennsylvania Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Connecticut Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Maine Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Vermont Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: New Hampshire Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: Rhode Island Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Delaware Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: South Region U.S. Connected Home Healthcare Devices Market: Regional Overview and Trends
TABLE 120: South Region U.S. Connected Home Healthcare Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 121: South Region U.S. Connected Home Healthcare Devices Market, by Product Category and Application, 2021–2035 (US$ Billion)
TABLE 122: South Region U.S. Connected Home Healthcare Devices Market, by End User and Technology Type, 2021–2035 (US$ Billion)
TABLE 123: Texas Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 124: Florida Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 125: Georgia Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: North Carolina Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Tennessee Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: South Carolina Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Alabama Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: Mississippi Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Louisiana Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Arkansas Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Kentucky Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Oklahoma Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Virginia Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Maryland Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: West Virginia Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Midwest Region U.S. Connected Home Healthcare Devices Market: Regional Overview and Trends
TABLE 139: Midwest Region U.S. Connected Home Healthcare Devices Market: Key Manufacturers and Procurement Ecosystem
TABLE 140: Midwest Region U.S. Connected Home Healthcare Devices Market, by Product Category and Application, 2021–2035 (US$ Billion)
TABLE 141: Midwest Region U.S. Connected Home Healthcare Devices Market, by End User and Technology Type, 2021–2035 (US$ Billion)
TABLE 142: Illinois Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 143: Ohio Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 144: Michigan Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 145: Minnesota Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Indiana Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Wisconsin Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Missouri Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Iowa Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Kansas Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Nebraska Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: North Dakota Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: South Dakota Connected Home Healthcare Devices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: U.S. Connected Home Healthcare Devices Market: Competitive Landscape Snapshot, 2025
TABLE 155: U.S. Connected Home Healthcare Devices Market: Key Company Market Share Analysis, 2025
TABLE 156: U.S. Connected Home Healthcare Devices Market: Company Positioning Matrix
TABLE 157: U.S. Connected Home Healthcare Devices Market: Product Portfolio Benchmarking of Key Players
TABLE 158: U.S. Connected Home Healthcare Devices Market: Connected-Care Capability Benchmarking
TABLE 159: U.S. Connected Home Healthcare Devices Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 160: Abbott Laboratories: Company Profile
TABLE 161: Dexcom, Inc.: Company Profile
TABLE 162: Medtronic plc: Company Profile
TABLE 163: Insulet Corporation: Company Profile
TABLE 164: Tandem Diabetes Care, Inc.: Company Profile
TABLE 165: ResMed Inc.: Company Profile
TABLE 166: Philips Healthcare: Company Profile
TABLE 167: GE HealthCare: Company Profile
TABLE 168: Baxter International Inc.: Company Profile
TABLE 169: Masimo Corporation: Company Profile
TABLE 170: OMRON Healthcare: Company Profile
TABLE 171: iRhythm Technologies, Inc.: Company Profile
TABLE 172: Boston Scientific Corporation: Company Profile
TABLE 173: AliveCor, Inc.: Company Profile
TABLE 174: BioIntelliSense, Inc.: Company Profile
TABLE 175: VitalConnect, Inc.: Company Profile
TABLE 176: Current Health / Best Buy Health: Company Profile
TABLE 177: TytoCare Ltd.: Company Profile
TABLE 178: Eko Health, Inc.: Company Profile
TABLE 179: Withings Health Solutions: Company Profile
TABLE 180: ZOLL Medical Corporation: Company Profile
TABLE 181: BIOTRONIK: Company Profile
TABLE 182: Roche Diabetes Care: Company Profile
TABLE 183: Ascensia Diabetes Care: Company Profile
TABLE 184: LifeScan, Inc.: Company Profile
TABLE 185: U.S. Connected Home Healthcare Devices Market: Future Market Scenario Analysis, 2026–2035
TABLE 186: U.S. Connected Home Healthcare Devices Market: Disruptive Technologies Impact Matrix
TABLE 187: U.S. Connected Home Healthcare Devices Market: Emerging Business Trends
TABLE 188: U.S. Connected Home Healthcare Devices Market: Business Opportunities for Startups and Existing Players
TABLE 189: U.S. Connected Home Healthcare Devices Market: Investment Prioritization Matrix
TABLE 190: U.S. Connected Home Healthcare Devices Market: Product Category Opportunity Matrix
TABLE 191: U.S. Connected Home Healthcare Devices Market: State-Level Opportunity Matrix
TABLE 192: U.S. Connected Home Healthcare Devices Market: Technology Adoption Roadmap, 2026–2035
TABLE 193: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for Device Manufacturers
TABLE 194: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for Hospitals and Health Systems
TABLE 195: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for RPM and Home Health Providers
TABLE 196: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for Payers and Risk-Bearing Organizations
TABLE 197: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 198: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 199: U.S. Connected Home Healthcare Devices Market: Strategic Recommendations for New Entrants and Startups
TABLE 200: U.S. Connected Home Healthcare Devices Market: Go-to-Market Strategy Considerations
TABLE 201: U.S. Connected Home Healthcare Devices Market: Product Positioning and Portfolio Expansion Guidance
TABLE 202: U.S. Connected Home Healthcare Devices Market: Reimbursement and Market Access Strategy
TABLE 203: U.S. Connected Home Healthcare Devices Market: Scope Limitation
TABLE 204: U.S. Connected Home Healthcare Devices Market: Market Definition and Inclusion/Exclusion Limitation
TABLE 205: U.S. Connected Home Healthcare Devices Market: Data Use Limitation
TABLE 206: U.S. Connected Home Healthcare Devices Market: Forecasting Limitation
TABLE 207: U.S. Connected Home Healthcare Devices Market: Regulatory and Reimbursement Change Limitation
TABLE 208: U.S. Connected Home Healthcare Devices Market: Legal Disclaimer
TABLE 209: U.S. Connected Home Healthcare Devices Market: Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Connected Home Healthcare Devices Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Market Ecosystem Framework
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: U.S. Connected Home Healthcare Devices Market Attractiveness Analysis
FIGURE 6: U.S. Connected Home Healthcare Devices Market Dynamics
FIGURE 7: Innovation & Patent Landscape, 2021–2025
FIGURE 8: Clinical Workflow Economics Framework
FIGURE 9: Connected Home Healthcare Procurement Decision Framework
FIGURE 10: Value Chain Analysis
FIGURE 11: Supply Chain Analysis
FIGURE 12: PESTEL Analysis
FIGURE 13: Porter’s Five Forces Analysis
FIGURE 14: U.S. Connected Home Healthcare Devices Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 15: U.S. Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 16: U.S. Connected Home Healthcare Devices Market Year-wise Growth Curve, 2021–2035
FIGURE 17: Product Category Segment Market Share Analysis, 2025 & 2035
FIGURE 18: Product Category Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Connected Physiological Monitoring Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 20: Connected Diabetes Management Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 21: Connected Respiratory and Sleep Therapy Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 22: Connected Medication and Therapy Adherence Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 23: Connected Safety, Aging-in-Place and Post-Acute Devices Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 24: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Application Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 26: Cardiovascular Disease and Hypertension Management Market Growth Analysis, 2021–2035
FIGURE 27: Diabetes and Metabolic Disease Management Market Growth Analysis, 2021–2035
FIGURE 28: Respiratory and Sleep Disease Management Market Growth Analysis, 2021–2035
FIGURE 29: Post-Acute, Transitional and Hospital-at-Home Care Market Growth Analysis, 2021–2035
FIGURE 30: Elderly Care and Multi-Chronic Disease Management Market Growth Analysis, 2021–2035
FIGURE 31: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 32: End User Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 33: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 34: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 35: Bluetooth, Wi-Fi and Cellular Connected Device Adoption Comparison
FIGURE 36: Hybrid Gateway and Multi-Device Platform Growth Analysis
FIGURE 37: Cloud-Integrated and AI-Enabled Device Architecture Opportunity Analysis
FIGURE 38: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 39: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 40: Direct Institutional vs Consumer-Led Procurement Dynamics
FIGURE 41: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 42: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: Regional Connected-Care Adoption and Opportunity Map
FIGURE 44: West Region U.S. Connected Home Healthcare Devices Market Share and Leading Players, 2025
FIGURE 45: West Region Market Share Analysis by State, 2025
FIGURE 46: West Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 47: California Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 48: Washington Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 49: Arizona Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 50: Colorado Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 51: Oregon Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 52: Utah Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 53: Nevada Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 54: New Mexico Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 55: Idaho Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 56: Montana Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 57: Wyoming Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 58: Alaska Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 59: Hawaii Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 60: Northeast Region U.S. Connected Home Healthcare Devices Market Share and Leading Players, 2025
FIGURE 61: Northeast Region Market Share Analysis by State, 2025
FIGURE 62: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 63: New York Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 64: Massachusetts Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 65: New Jersey Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 66: Pennsylvania Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 67: Connecticut Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 68: Maine Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 69: Vermont Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 70: New Hampshire Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 71: Rhode Island Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 72: Delaware Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 73: South Region U.S. Connected Home Healthcare Devices Market Share and Leading Players, 2025
FIGURE 74: South Region Market Share Analysis by State, 2025
FIGURE 75: South Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 76: Texas Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 77: Florida Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 78: Georgia Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 79: North Carolina Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 80: Tennessee Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 81: South Carolina Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 82: Alabama Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 83: Mississippi Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 84: Louisiana Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 85: Arkansas Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 86: Kentucky Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 87: Oklahoma Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 88: Virginia Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 89: Maryland Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 90: West Virginia Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 91: Midwest Region U.S. Connected Home Healthcare Devices Market Share and Leading Players, 2025
FIGURE 92: Midwest Region Market Share Analysis by State, 2025
FIGURE 93: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035
FIGURE 94: Illinois Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 95: Ohio Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 96: Michigan Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 97: Minnesota Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 98: Indiana Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 99: Wisconsin Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 100: Missouri Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 101: Iowa Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 102: Kansas Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 103: Nebraska Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 104: North Dakota Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 105: South Dakota Connected Home Healthcare Devices Market Size, Forecast and Trend Analysis, 2021–2035
FIGURE 106: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 107: Company Positioning Matrix
FIGURE 108: Key Player Product Portfolio Benchmarking
FIGURE 109: Connected-Care Capability Benchmarking
FIGURE 110: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 111: Connected Home Healthcare Device Innovation Roadmap
FIGURE 112: Continuous Glucose Monitoring and Connected Diabetes Technology Roadmap
FIGURE 113: Remote Physiologic Monitoring Growth Roadmap
FIGURE 114: Hospital-at-Home Connected Device Opportunity Map
FIGURE 115: AI-Enabled Home Monitoring Adoption Roadmap
FIGURE 116: Future Market Scenario Analysis, 2026–2035
FIGURE 117: Disruptive Technologies Impact Matrix
FIGURE 118: Emerging Business Trends Matrix
FIGURE 119: Investment Prioritization Matrix
FIGURE 120: Product Category Opportunity Matrix
FIGURE 121: State-Level Commercial Opportunity Matrix
FIGURE 122: Strategic Growth Roadmap for U.S. Connected Home Healthcare Device Companies
FIGURE 123: Go-to-Market Strategy Framework
FIGURE 124: Reimbursement and Market Access Framework
FIGURE 125: Provider and Payer Partnership Strategy Framework
FIGURE 126: Product Positioning and Portfolio Expansion Framework
FIGURE 127: Cybersecurity and Interoperability Readiness Framework
FIGURE 128: Report Scope, Market Boundary and Disclaimer Framework